Search Results - Peter H Goff

  • Showing 1 - 7 results of 7
Refine Results
  1. 1

    Oncolytic Newcastle disease virus expressing a checkpoint inhibitor as a radioenhancing agent for murine melanoma by Gayathri Vijayakumar, Peter Palese, Peter H. Goff

    Published in EBioMedicine (2019-11-01)
    Get full text
    Article


  2. 2

    Merkel cell carcinoma refractory to anti-PD(L)1: utility of adding ipilimumab for salvage therapy by Shailender Bhatia, Paul Nghiem, Tomoko Akaike, Song Y Park, Peter H Goff, Austin J Jabbour

    Published in Journal for ImmunoTherapy of Cancer (2024-07-01)
    Get full text
    Article


  3. 3

    Adjuvants and immunization strategies to induce influenza virus hemagglutinin stalk antibodies. by Peter H Goff, Dirk Eggink, Christopher W Seibert, Rong Hai, Luis Martínez-Gil, Florian Krammer, Peter Palese

    Published in PLoS ONE (2013-01-01)
    Get full text
    Article


  4. 4

    610 ImmunoRad: a stratified phase II trial of image guided hypofractionated radiotherapy with concurrent nelfinavir & PD-1 inhibition in advanced melanoma, lung cancer & renal cell... by Shailender Bhatia, Ramesh Rengan, Sylvia M Lee, Scott S Tykodi, Jing Zeng, Mary Redman, Peter H Goff, Kelsey K Baker

    Published in Journal for ImmunoTherapy of Cancer (2023-11-01)
    Article


  5. 5

    2D kV orthogonal imaging with fiducial markers is more precise for daily image guided alignments than soft-tissue cone beam computed tomography for prostate radiation therapy by Peter H. Goff, MD, PhD, Louis B. Harrison, MD, FASTRO, Eli Furhang, PhD, Evan Ng, MBBS, FRANZCR, Stephen Bhatia, RTT, Frieda Trichter, DSc, Ronald D. Ennis, MD

    Published in Advances in Radiation Oncology (2017-07-01)
    Get full text
    Article


  6. 6

    Intratumoral STING agonist reverses immune evasion in PD-(L)1-refractory Merkel cell carcinoma: mechanistic insights from detailed biomarker analyses by Shailender Bhatia, Paul Nghiem, Rima Kulikauskas, Candice Church, David M Koelle, Lisa Tachiki, Kimberly Smythe, Thomas Pulliam, Shira Tabachnick-Cherny, Saumya Jani, Peter H Goff, Rashmi Bhakuni, Brandon W Seaton

    Published in Journal for ImmunoTherapy of Cancer (2024-10-01)
    Get full text
    Article


  7. 7

    Postoperative Radiation Therapy Is Indicated for “Low-Risk” Pathologic Stage I Merkel Cell Carcinoma of the Head and Neck Region but Not for Other Locations by Marika M. Bierma, BS, BA, Peter H. Goff, MD, PhD, Daniel S. Hippe, MS, Kristina Lachance, MS, Stephanie K. Schaub, MD, Kent Wallner, MD, Yolanda D. Tseng, MD, Jay J. Liao, MD, Smith Apisarnthanarax, MD, Paul Nghiem, MD, PhD, Upendra Parvathaneni, MBBS, FRANZCR

    Published in Advances in Radiation Oncology (2024-02-01)
    Get full text
    Article


Search Tools: